MedTrace Logo

Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.

NCT07737782 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-07-30

No results posted yet for this study

Summary

The goal of this clinical trial is to retrospectively identify the most prevalent symptoms of genitourinary syndrome of menopause (GSM) among postmenopausal women and to evaluate their impact on quality of life. Moreover, based on data collected from medical records and/or patient-reported questionnaires, if available data enable it, it will be assessed whether treatment with the topical vulvovaginal gel XCM INTIM for a minimum of 8 weeks results in changes in symptom severity and in the impact of these symptoms across different quality-of-life domains.

Conditions

  • Vulvar Atrophy
  • Vulvovaginal Signs and Symptoms
  • Genitourinary Syndrome of Menopause (GSM)
  • Quality of Life
  • Menopause Related Conditions
  • Dyspareunia
  • Urinary Incontinence, Urgency-frequency
  • Sexual Function
  • Women´s Health
  • Vaginal Dryness

Sponsors & Collaborators

  • Hospital Universitario La Luz Quirónsalud

    collaborator UNKNOWN

  • Clínica Vilaboa

    collaborator UNKNOWN

  • Mucosa Innovations, S.L.

    lead INDUSTRY

Principal Investigators

  • Manuel Albi-González, MD · Hospital Universitario La Luz Quirónsalud

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737782 on ClinicalTrials.gov